Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer
Cameron C. Wick
, Rod P. Rezaee
, Tammy Wang
, Andrea M. Garcia-Jarchow
, Chad A. Zender
, Michael Gibson
,
Min Yao
, Pierre Lavertu
Department of Radiation Oncology
Penn State Cancer Institute
Cancer Institute, Next-Generation Therapies
Research output
:
Contribution to journal
›
Article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Concurrent Chemoradiation
100%
Total Laryngectomy
50%
Tracheotomy
50%
Adjuvant Radiation
50%
Gastric Tube
50%
Concurrent Chemoradiation Therapy
50%
Overall Survival
25%
5-year Survival
25%
Treatment Modalities
25%
University Hospital
25%
Recurrence Rate
25%
Worse Outcome
25%
Distant Metastasis
25%
Definitive Treatment
25%
Kaplan-Meier
25%
Chart Review
25%
Regional Metastasis
25%
Surgical Conditions
25%
Chemoradiation Therapy
25%
Locoregional Recurrence
25%
Laryngeal Diseases
25%
Medicine and Dentistry
Chemoradiotherapy
100%
Laryngeal Cancer
100%
Laryngectomy
66%
Chemoradiation Therapy
50%
Overall Survival
33%
Tracheotomy
33%
Neck
16%
Recurrence Risk
16%
Distant Metastasis
16%
Diseases
16%